| |
| |
|
| Insider
Information: |
Hoerter Steven L. |
| Relationship: |
|
| City: |
Boulder |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
83,704 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,205,590 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
83,704 |
|
|
| Total
Value |
$2,205,590 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 171.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clovis Oncology, Inc. |
CLVS |
See Remarks |
2015-03-05 |
0 |
2013-06-04 |
0 |
Premium* |
|
|
Agios Pharmaceuticals Inc |
AGIO |
Chief Commercial Officer |
2019-03-04 |
10,941 |
2018-01-23 |
0 |
Premium* |
|
|
Deciphera Pharmaceuticals, Inc. |
DCPH |
|
2023-12-13 |
72,763 |
2019-03-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DCPH |
Deciphera Pharmaceuticals... |
President and CEO |
• • – |
2023-12-13 |
4 |
S |
$15.37 |
$471,217 |
D/D |
(30,664) |
72,763 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
President and CEO |
• • – |
2023-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
62,500 |
103,427 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
President and CEO |
• • – |
2023-10-30 |
4 |
S |
$12.02 |
$259,256 |
D/D |
(21,573) |
40,927 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
President and CEO |
• • – |
2023-10-28 |
4 |
A |
$0.00 |
$0 |
D/D |
62,500 |
62,500 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
President and CEO |
• • – |
2023-03-21 |
4 |
AS |
$15.57 |
$116,782 |
D/D |
(7,500) |
0 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
President and CEO |
• • – |
2023-02-14 |
4 |
AS |
$16.00 |
$480,720 |
D/D |
(30,045) |
7,500 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
President and CEO |
• • – |
2022-03-21 |
4 |
D |
$9.11 |
$28,697 |
D/D |
(3,150) |
37,545 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
President and CEO |
• • – |
2021-03-18 |
4 |
D |
$42.39 |
$135,500 |
D/D |
(3,150) |
40,695 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
President and CEO |
• • – |
2021-01-21 |
4 |
OE |
$25.40 |
$27,381 |
D/D |
1,078 |
43,845 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
President and CEO |
• • – |
2020-08-20 |
4 |
OE |
$25.40 |
$4,750 |
D/D |
187 |
42,767 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
President and CEO |
• • – |
2020-07-20 |
4 |
OE |
$25.40 |
$4,775 |
D/D |
188 |
42,580 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
President and CEO |
• • – |
2020-06-18 |
4 |
OE |
$25.40 |
$4,750 |
D/D |
187 |
42,392 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
President and CEO |
• • – |
2020-05-28 |
4 |
OE |
$25.40 |
$4,775 |
D/D |
188 |
42,205 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
President and CEO |
• • – |
2020-04-21 |
4 |
OE |
$25.40 |
$4,750 |
D/D |
187 |
42,017 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
President and CEO |
• • – |
2020-03-19 |
4 |
D |
$35.78 |
$465,619 |
D/D |
(12,420) |
41,830 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
President and CEO |
• • – |
2020-03-18 |
4 |
OE |
$25.40 |
$57,150 |
D/D |
2,250 |
54,250 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
President & CEO |
• • – |
2019-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
52,000 |
52,000 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2019-03-04 |
4 |
S |
$68.00 |
$340,000 |
D/D |
(5,000) |
10,941 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2019-03-04 |
4 |
OE |
$39.76 |
$198,800 |
D/D |
5,000 |
15,941 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2019-03-01 |
4 |
OE |
$39.76 |
$198,800 |
D/D |
5,000 |
15,941 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2019-03-01 |
4 |
S |
$66.01 |
$330,050 |
D/D |
(5,000) |
10,941 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2019-02-19 |
4 |
D |
$58.03 |
$60,351 |
D/D |
(1,040) |
10,941 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2019-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,750 |
11,981 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2019-01-22 |
4 |
D |
$52.82 |
$304,719 |
D/D |
(5,769) |
9,231 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2019-01-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
